Aug. 25 (Bloomberg) -- Dynegy Inc. agreed to buy $6.25 billion of power plants from Duke Energy Corp. and private-equity firm Energy Capital Partners, almost doubling its generating capacity less than a year after emerging from bankruptcy protection.
White & Case LLP represented Dynegy in its deal with Duke, which was advised by Bracewell & Giuliani LLP. Representing Dynegy in the Energy Capital deal was Skadden, Arps, Slate, Meagher & Flom LLP; Latham & Watkins LLP advised Energy Capital.
White & Case mergers partner Michael Shenberg advised Dynegy on its purchase of assets from Duke. Partners working on the financing of the deals included Eric Berg, banking, and Gary Kashar, David Johansen and Colin Diamond, all capital markets.
Bracewell & Giuliani partners representing Duke Energy were John Klauberg, Frederick J. Lark, Kristen Campana, Daniel Hemli, Bruce Jocz, Elizabeth McGinley, Aaron Roffwarg, Robert Sheeder, Charles Vandenburgh and Timothy Wilkins.
From Skadden representing Dynegy on the Energy Capital deal were partners Michael Rogan, mergers and acquisitions, John Lyons, antitrust and competition, William Conway Jr., energy regulation and litigation, Sean Shimamoto, tax, and Ann Hawkins, project finance, along with counsel Erik Elsea, mergers and acquisitions.
From Latham representing Energy Capital were partners David Kurzweil, Paul Kukish and Jeff Greenberg.
The sale includes $2.8 billion for 11 Duke natural gas, coal and oil power plants in Ohio, Pennsylvania and Illinois as well as its retail sales business, Houston-based Dynegy said in a statement Aug. 22.
In a separate transaction, Dynegy is spending $3.45 billion for Energy Capital plants in Massachusetts, Connecticut, Pennsylvania, Illinois and Ohio.
Duke is one of several utility owners seeking to divest itself of power plants that compete for buyers on wholesale markets, instead favoring returns from units with customers paying regulated rates. The last of Dynegy’s subsidiaries emerged from bankruptcy protection in November 2013, after a collapse in wholesale electricity prices drove several years of losses for the independent power producer.
For more on the deal, click here.
Hunton & Williams Adds Partner to Its Real Estate Practice
Robert Johnson joined the Los Angeles office of Hunton & Williams LLP as a partner in Los Angeles. Johnson, previously a partner at Seyfarth Shaw LLP, focuses on commercial real estate development and finance. Johnson represents owners and investors in acquiring, leasing and developing office, retail and industrial property throughout the Western U.S., the firm said. Christopher Hasbrouck, also from Seyfarth Shaw, will join as an associate to work with Johnson.
McKenna Long Adds Aviation Expert Wilson to New York Office
Diane Westwood Wilson joined McKenna Long & Aldridge LLP’s aviation and transportation practice as a partner in New York.
Wilson, formerly a senior equity partner at Clyde & Co LLP, represents aviation industry and insurer interests internationally in complex aerospace, aviation, product-liability and construction disputes. Her experience includes work on a U.S. Supreme Court treaty case.
Shutts & Bowen Adds Litigator Daniel Nordby in Tallahassee
Daniel Nordby, a civil litigator with experience in Florida government, joined Shutts & Bowen LLP as a partner in Tallahassee. Nordby most recently served as general counsel to the Florida House of Representatives under Speaker Will Weatherford. He has also served as general counsel to Florida’s secretary of state and, in private practice, as outside general counsel to the Republican Party of Florida.
In his new position, Nordby is advising clients on matters before government agencies and in the courts.
Kilpatrick Townsend Expands Health and Life Science Practice
Andrew Serafini has joined Kilpatrick Townsend & Stockton LLP as a partner in the intellectual-property group’s health and life sciences team in Seattle. Serafini was previously a partner at Fenwick & West LLP.
Serafini, who has a PhD in immunology, focuses his practice on representing biotechnology, biopharmaceutical and other life-sciences clients on intellectual property strategy and counseling. He has worked on the development of patent portfolios in numerous areas, the firm said in a statement.
To contact the reporter on this story: Ellen Rosen in New York at firstname.lastname@example.org
To contact the editors responsible for this story: Michael Hytha at email@example.com Charles Carter, David E. Rovella